{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:35:32Z","timestamp":1794548132044,"version":"4.9.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012068","name":"Health and Care Research Wales","doi-asserted-by":"publisher","award":["18\/NW\/0827"],"award-info":[{"award-number":["18\/NW\/0827"]}],"id":[{"id":"10.13039\/100012068","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010311","name":"Guts UK","doi-asserted-by":"publisher","award":["DG201802"],"award-info":[{"award-number":["DG201802"]}],"id":[{"id":"10.13039\/501100010311","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.heliyon.2023.e21861","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T14:58:40Z","timestamp":1699369120000},"page":"e21861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Improving detection of cystic fibrosis related liver disease using liver fibrosis assessment tools"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6112-2093","authenticated-orcid":false,"given":"Jennifer A.","family":"Scott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3232-1055","authenticated-orcid":false,"given":"Andrew M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2556-3777","authenticated-orcid":false,"given":"Elliot","family":"Jokl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Gordon-Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6326-4431","authenticated-orcid":false,"given":"Peter J.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3234-4038","authenticated-orcid":false,"given":"Neil A.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Piper Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1684-721X","authenticated-orcid":false,"given":"Varinder S.","family":"Athwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.heliyon.2023.e21861_bib1","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/hep.30148","article-title":"Cystic fibrosis liver disease: outcomes and risk factors in a large cohort of French patients","volume":"69","author":"Bo\u00eblle","year":"2019","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e21861_bib2","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.510300527","article-title":"Natural history of liver disease in cystic fibrosis","volume":"30","author":"Lindblad","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2023.e21861_bib3","series-title":"UK Cystic Fibrosis Registry Annual Data Report 2016","author":"Jeffery","year":"2017"},{"issue":"Pt 2","key":"10.1016\/j.heliyon.2023.e21861_bib4","first-page":"357","article-title":"Cystic fibrosis in adults: an autopsy study","volume":"14","author":"Vawter","year":"1979","journal-title":"Pathol. Annu."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e21861_bib5","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.cgh.2018.10.046","article-title":"Obliterative portal venopathy without cirrhosis is prevalent in pediatric cystic fibrosis liver disease with portal hypertension","volume":"17","author":"Wu","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e21861_bib6","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/MCP.0000000000000824","article-title":"Emerging clinical perspectives in cystic fibrosis liver disease","volume":"27","author":"Athwal","year":"2021","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e21861_bib7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/MOG.0000000000000624","article-title":"Hepatic manifestations of cystic fibrosis","volume":"36","author":"Dana","year":"2020","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e21861_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212779","article-title":"The emerging burden of liver disease in cystic fibrosis patients: a UK nationwide study","volume":"14","author":"Toledano","year":"2019","journal-title":"PLoS One"},{"issue":"Suppl 2","key":"10.1016\/j.heliyon.2023.e21861_bib9","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S1569-1993(11)60006-4","article-title":"Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease","volume":"10","author":"Debray","year":"2011","journal-title":"J. Cyst. Fibros."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e21861_bib10","doi-asserted-by":"crossref","first-page":"13529","DOI":"10.3390\/ijms150813529","article-title":"Cystic fibrosis related liver disease--another black box in hepatology","volume":"15","author":"Staufer","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e21861_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jcf.2007.08.001","article-title":"Comparison of ultrasound and biopsy findings in children with cystic fibrosis related liver disease","volume":"7","author":"Mueller-Abt","year":"2008","journal-title":"J. Cyst. Fibros."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e21861_bib12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10396-015-0684-7","article-title":"Discordance between conventional ultrasonography and ElastPQ for assessing hepatic fibrosis in chronic hepatitis B: frequency and independent factors","volume":"43","author":"Kim","year":"2016","journal-title":"J. Med. Ultrason."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21861_bib13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/hep.24014","article-title":"Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy","volume":"53","author":"Lewindon","year":"2011","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e21861_bib14","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/j.cgh.2019.03.015","article-title":"Accuracy of transient elastography data combined with APRI in detection and staging of liver disease in pediatric patients with cystic fibrosis","volume":"17","author":"Lewindon","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e21861_bib15","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/liv.12113","article-title":"Utility of transient elastography in the non-invasive evaluation of cystic fibrosis liver disease","volume":"33","author":"Kitson","year":"2013","journal-title":"Liver Int."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e21861_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042139","article-title":"Non-invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scores","volume":"7","author":"Karlas","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e21861_bib17","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jcf.2013.04.004","article-title":"ARFI and transient elastography for characterization of cystic fibrosis related liver disease: first longitudinal follow-up data in adult patients","volume":"12","author":"Karlas","year":"2013","journal-title":"J. Cyst. Fibros."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e21861_bib18","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/hep.28016","article-title":"Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease","volume":"62","author":"Leung","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e21861_bib19","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jcf.2020.05.002","article-title":"A longitudinal assessment of non-invasive biomarkers to diagnose and predict cystic fibrosis-associated liver disease","volume":"19","author":"Karnsakul","year":"2020","journal-title":"J. Cyst. Fibros."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e21861_bib20","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jcf.2009.08.001","article-title":"Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease","volume":"8","author":"Witters","year":"2009","journal-title":"J. Cyst. Fibros."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e21861_bib21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jcf.2019.09.016","article-title":"Occurrence, outcomes and predictors of portal hypertension in cystic fibrosis: a longitudinal prospective birth cohort study","volume":"19","author":"Cipolli","year":"2020","journal-title":"J. Cyst. Fibros."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e21861_bib22","first-page":"139","article-title":"Noninvasive methods, including transient elastography, for the detection of liver disease in adults with cystic fibrosis","volume":"29","author":"Sadler","year":"2015","journal-title":"Chin. J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e21861_bib23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/hep.29217","article-title":"Adult-onset cystic fibrosis liver disease: diagnosis and characterization of an underappreciated entity","volume":"66","author":"Koh","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2023.e21861_bib24","doi-asserted-by":"crossref","DOI":"10.1097\/MCP.0000000000000824","article-title":"Emerging clinical perspectives in cystic fibrosis liver disease","author":"Athwal","year":"2021","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.heliyon.2023.e21861_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3762651","article-title":"Defining an optimal cut-point value in ROC analysis: an alternative approach","volume":"2017","author":"Unal","year":"2017","journal-title":"Comput. Math. Methods Med."},{"key":"10.1016\/j.heliyon.2023.e21861_bib26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12876-015-0414-z","article-title":"Liver and spleen transient elastography predicts portal hypertension in patients with chronic liver disease: a prospective cohort study","volume":"15","author":"Zykus","year":"2015","journal-title":"BMC Gastroenterol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e21861_bib27","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis","volume":"53","author":"Lin","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21861_bib28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2017-314924","article-title":"Guidelines on the management of abnormal liver blood tests","volume":"67","author":"Newsome","year":"2018","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.heliyon.2023.e21861_bib29","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/gutjnl-2015-309260","article-title":"The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa","volume":"65","author":"Lemoine","year":"2016","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e21861_bib30","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1183\/09031936.00099506","article-title":"Cystic fibrosis mortality and survival in the UK: 1947-2003","volume":"29","author":"Dodge","year":"2007","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.heliyon.2023.e21861_bib31","series-title":"Review Article: Epidemiology, Pathogenesis and Management of Liver Disease in Adults with Cystic Fibrosis","author":"Scott","year":"2022"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e21861_bib32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcf.2012.11.010","article-title":"Cirrhosis and other liver disease in cystic fibrosis","volume":"12","author":"Flass","year":"2013","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.heliyon.2023.e21861_bib33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2147\/CEG.S160537","article-title":"Liver function tests in identifying patients with liver disease","volume":"11","author":"Ahmed","year":"2018","journal-title":"Clin. Exp. Gastroenterol."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e21861_bib34","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1478-3231.2006.01304.x","article-title":"The AST\/ALT ratio as an indicator of cirrhosis in patients with PBC","volume":"26","author":"Nyblom","year":"2006","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21861_bib35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e21861_bib36","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e21861_bib37","first-page":"367","article-title":"An assessment of the clinical accuracy of ultrasound in diagnosing cirrhosis in the absence of portal hypertension","volume":"14","author":"Kelly","year":"2018","journal-title":"Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e21861_bib38","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jcf.2017.03.006","article-title":"Liver disease in cystic fibrosis presents as non-cirrhotic portal hypertension","volume":"16","author":"Witters","year":"2017","journal-title":"J. Cyst. Fibros."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e21861_bib39","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jcf.2020.06.006","article-title":"The emergence of elastography for cystic fibrosis liver disease","volume":"19","author":"Masand","year":"2020","journal-title":"J. Cyst. Fibros."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e21861_bib40","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J. Hepatol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023090692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023090692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:12:03Z","timestamp":1791292323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023090692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2405844023090692"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21861","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving detection of cystic fibrosis related liver disease using liver fibrosis assessment tools","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21861","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e21861"}}